Purchase Order 75N98026P00843
Award Date 6/25/26
Potential Completion Date 6/24/27
Potential Value $32K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Office of Logistics and Acquisition Operations awarded a purchase order to Psomagen Inc. for $89,790 on January 30, 2020, for RNA extraction from Paxgene RNA tubes. The order was set aside for total small business and was firm fixed price. Performance occurs in Bethesda, Maryland, with a completion date of March 30, 2020. The purchase order was issued under a Total Small Business set-aside solicitation posted December 30, 2019, with proposals due January 6, 2020.</p>
- This is a $37,814 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. The contract is for the extraction of total RNA from whole blood samples in support of research activities at the National Human Genome Research Institute (NHGRI), another NIH agency. The contract was awarded on July 10, 2020 through full and open competition, with a period of performance ending on March 31,...
- <p>The Food and Drug Administration awarded a purchase order to University of Maryland, Baltimore on September 7, 2022, for RNA extraction, quality control assessment, library preparation, and Illumina sequencing of 200 peripheral blood samples collected in Paxgene tubes, with a ceiling value of $54,999.98 and completion date of September 29, 2023. Work is performed in Baltimore, Maryland. The order carries no set-aside designation and is priced on a firm fixed price basis.</p>
- <p>The Office of Logistics and Acquisition Operations issued a purchase order to Psomagen Inc. for H/M/R total RNA sequencing with a ceiling value of $48,750.00 and an award date of April 5, 2021. Performance is located in Rockville, Maryland, with work completion required by May 4, 2021. The order covers advanced RNA sequencing services under firm fixed-price terms with no set-aside designation.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Reprocell U.S.A., Inc. for DNA and RNA extraction from whole blood with a ceiling value of $73,338.90, effective April 15, 2020, and completing April 14, 2021. Work is performed at Calverton, Maryland. The order is firm fixed price with no small business set-aside.</p>
- <p>The National Human Genome Research Institute awarded a purchase order to Reprocell U.s.a., Inc. for $18,398.20 on January 30, 2020, for DNA extractions. Work is performed at Calverton, Maryland. The order is firm fixed price with an ultimate completion date of February 29, 2020.</p>
- This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. for $17,016.80. The contract was awarded on January 5, 2023 with a completion date of July 5, 2023. The contract supports genetic and epigenetic analysis at the transcriptome level, which is a critical component of the Comprehensive Disease Study (CDS) program's integrative research...
- The federal contract award 75N95D24P00067 was made by the National Institute on Aging (NIA), a civilian agency within the U.S. government, to Reprocell U.S.A., Inc., a for-profit organization, for laboratory testing services related to RNA and DNA extraction from mouse and human models. The $20,902.50 firm fixed price contract has a period of performance through July 30, 2024. The contract was awarded under full and open competition with no set-aside designation. Reprocell U.S.A., Inc. has...
- This is a $24,917.48 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for RNA isolation services. The contract is not set aside and has an ultimate completion date of June 11, 2025. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has provided various products and services...
- The Department of Defense issued a delivery order to Government Scientific Source Inc. on May 13, 2026, with a ceiling value of $53,315.65 for a DNA/RNA extraction and purification system capable of processing 48 samples in parallel using a cartridge-based reagent and sample processing system. The order is issued under the General Services Administration's Multiple Award Schedule (MAS). Place of performance is Kearneysville, West Virginia. Performance is due by June 12, 2026. Pricing is firm...